Abstract
Abstract Background: The real-world effectiveness of insulin therapy is influenced by poor treatment persistence. An international cross-sectional survey of people with type 2 diabetes mellitus (T2DM) was conducted to
Highlights
The costs of diabetes to the Spanish healthcare system are high, The prevalence of diabetes mellitus adjusted for age and sex in Spain reaching 8.2% of all expenditures in 2012
The benefits of basal insulin therapy motivated continuers to persist with the treatment, whereas experienced or anticipated side effects and injection concerns contributed to interruption and discontinuation
A higher percentage of interrupters (78%) had prior use of antihyperglycaemic drugs (AHDs) before insulin compared with continuers (44%) and discontinuers (42%)
Summary
The costs of diabetes to the Spanish healthcare system are high, The prevalence of diabetes mellitus adjusted for age and sex in Spain reaching 8.2% of all expenditures in 2012. The recommended target levels of glycated haemoglobin (HbA1c) from the Spanish treatment guidelines are
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
